Vaccine Information: HEPLISAV-B (Page 3 of 3)
16 HOW SUPPLIED/STORAGE AND HANDLING
16.1 How Supplied
- Prefilled syringe, 1 dose (0.5 mL) — (NDC number: 43528-003-01)
- Package of 5 single dose prefilled syringes — (NDC number: 43528-003-05)
The tip caps and stoppers of the prefilled syringes are not made with natural rubber latex.
16.2 Storage Conditions
Store in a refrigerator at 2°C to 8°C (36°F to 46°F).
Do not freeze; discard if the vaccine has been frozen.
Do not use the vaccine after the expiration date shown on the prefilled syringe label.
17 PATIENT COUNSELING INFORMATION
- Inform vaccine recipient of the potential benefits and risks associated with vaccination, as well as the importance of completing the immunization series.
- Emphasize that HEPLISAV-B contains non-infectious purified HBsAg and cannot cause hepatitis B infection.
- Advise vaccine recipient to report any adverse events to their healthcare provider or to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 and www.vaers.hhs.gov.
- Provide the Vaccine Information Statements, which are available free of charge at the Centers for Disease Control and Prevention (CDC) website (www.cdc.gov/vaccines).
DYNAVAX
Manufactured by:
Dynavax Technologies Corporation
Emeryville, CA 94608 USA
© 2017 — 2023, Dynavax Technologies Corporation.
All rights reserved.
Principal Panel — Carton — Vials
Rx only
Hepatitis B Vaccine
(Recombinant),
Adjuvanted
HEPLISAV-B™
NDC 43528-002-05
5 x 0.5 mL
single-dose vials
For intramuscular administration only
DYNAVAX
Principal Panel — Carton — Prefilled Syringes
NDC 43528-003-05 Rx only
Hepatitis B Vaccine
(Recombinant),
Adjuvanted
HEPLISAV-B®
5 x 0.5 mL single-dose syringes
For intramuscular administration only
For Adult Use Only
NEEDLES NOT INCLUDED
DYNAVAX
Principal Panel — Label — Prefilled Syringes
HEPLISAV-B®
1 dose (0.5 mL)
Hepatitis B Vaccine
(Recombinant), Adjuvanted
NDC 43528-003-01 Rx only
For IM use only DO NOT FREEZE
Store at 2-8°C (36-46°F)Mfd. by Dynavax Tech. Corp.
HEPLISAV-B hepatitis b vaccine (recombinant) adjuvanted injection, solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
HEPLISAV-B hepatitis b vaccine (recombinant) adjuvanted injection, solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
Labeler — Dynavax Technologies Corporation (964173801) |
Registrant — Dynavax Technologies Corporation (964173801) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Rhein Biotech GmbH | 318031242 | ANALYSIS (43528-002), API MANUFACTURE (43528-002), ANALYSIS (43528-003), API MANUFACTURE (43528-003) |
Revised: 05/2023 Dynavax Technologies Corporation
VxLabels.com provides trustworthy package insert and label information about marketed drugs and vaccines as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VxLabels.com. Every individual vaccine label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.